文献速递血栓与止血

出血性疾病中DDAVP反应及其决定因素:系统评价与荟萃分析

DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis.
PubMed 文献 · Blood · 2025-01-01

该系统评价与荟萃分析共纳入103篇文章,其中71篇(1772例患者)符合反应定义。血友病A的基线FVIII:C为边缘显著决定因素,VWD 1型的VWF:Ag、VWF活性和FVIII:C为显著决定因素。

要点

  • 血友病A中基线FVIII:C为反应的边缘显著决定因素。
  • VWD 1型中VWF:Ag、VWF活性和FVIII:C为反应的显著决定因素。

核心结论

  • DDAVP反应在不同疾病亚型间存在差异,血友病A主要取决于基线FVIII:C,VWD主要取决于基线VWF:Ag。
  • 作者强调需标准化反应定义并进一步研究反应机制。

研究设计与样本

  • 系统评价与荟萃分析,纳入接受DDAVP的任何出血性疾病患者研究,第一轮和第二轮筛选及偏倚风险评估由独立评审员完成。
  • 共检索到591篇文章,纳入103篇;其中71篇(1772例患者)符合本研究反应定义。

主要发现

  • 血友病A中基线FVIII:C为反应的边缘显著决定因素。
  • VWD 1型中VWF:Ag、VWF活性和FVIII:C为反应的显著决定因素。
  • 特定VWF和FVIII突变间观察到反应存在较大变异。

关键数值与推荐

  • 完全反应定义为因子水平>50 U/dL,部分反应定义为30–50 U/dL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需标准化反应定义并进一步研究反应机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Desmopressin (1-desamino-8-d-arginine vasopressin [DDAVP]) can be used to prevent or stop bleeding. However, large interindividual variability is observed in DDAVP response and determinants are largely unknown. In this systematic review and meta-analysis, we aimed to identify the response to DDAVP and the factors that determine DDAVP response in patients. We included studies with patients with any bleeding disorder receiving DDAVP. First and second screening round and risk of bias assessment were performed by independent reviewers. The main outcome was proportion of patients with complete (factor level >50 U/dL) or partial (30-50 U/dL) response to DDAVP. Determinants of response including disease type, age, sex, von Willebrand factor (VWF) and factor VIII (FVIII) mutations, and baseline factor levels were investigated. In total, 591 articles were found and 103 were included. Of these, 71 articles (1772 patients) were suitable for the study's definition of response. Meta-analysis showed a pooled response proportion of 0.71 (0.64; 0.78) and a significant difference in response between disease subtypes. For hemophilia A, baseline FVIII activity (FVIII:C) was a borderline significant determinant of response. In patients with von Willebrand disease (VWD) type 1, VWF antigen (VWF:Ag), VWF activity, and FVIII:C were significant determinants. A large variation in response was observed for specific mutations in VWF and FVIII. Response to DDAVP varied between disease subtypes and was largely determined by the baseline levels of FVIII:C for hemophilia A and VWF:Ag for VWD. Our findings highlight the significant differences in response and emphasize the need for a standardized response definition and further research into response mechanisms.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Laan S, Del Castillo Alferez J, Cannegieter S, et al. DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis. Blood. 2025. PMID: 39854691. doi:10.1182/blood.2024026804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。